Related Experiment Videos
Regulatory elements in the insulin-responsive glucose transporter (GLUT4) gene
1Division of Clinical Nutrition, National Institute of Health and Nutrition, 1-23-1, Tokyo, Shinjuku-ku, 162, Japan.
Biochemical and Biophysical Research Communications
|February 12, 1998
Summary
Increasing glucose transporter type 4 (GLUT4) expression can improve glycemic control and alleviate insulin resistance. This review explores GLUT4 gene regulation and promoter elements, offering insights into potential therapeutic strategies.
Area of Science:
- Metabolism and Endocrinology
- Molecular Biology
Background:
- Glucose transporter type 4 (GLUT4) is crucial for insulin-sensitive glucose uptake in muscle and adipose tissue.
- GLUT4 expression is modulated by physiological states like exercise, fasting, and hormonal treatments.
- Dysregulation of GLUT4 is implicated in insulin resistance, obesity, and diabetes.
Purpose of the Study:
- To review recent findings on the regulation of the GLUT4 gene.
- To discuss progress in identifying regulatory elements within the GLUT4 gene promoter.
- To highlight the potential of modulating GLUT4 expression as a strategy for managing insulin resistance.
Main Methods:
- Literature review of studies on GLUT4 gene regulation.
- Analysis of research on GLUT4 promoter elements and their function.
- Synthesis of data from studies investigating GLUT4 modulation in models of insulin resistance.
Main Results:
- GLUT4 expression is influenced by various factors including exercise, thyroid hormones, fasting, diabetes, obesity, and denervation.
- Overexpression of GLUT4 has shown significant improvements in glycemic control in insulin-resistant mouse models.
- Identification of key regulatory elements in the GLUT4 promoter is advancing.
Conclusions:
- Modulating GLUT4 expression presents a promising therapeutic avenue for combating insulin resistance.
- Understanding GLUT4 gene regulation is essential for developing effective strategies to improve glucose metabolism.
- Further research into GLUT4 promoter elements could unlock novel treatment approaches for metabolic disorders.